The global congestive heart failure (CHF) treatment devices market was valued at USD 5.6 billion in 2024 and is projected to reach USD 8.2 billion by 2030, growing at a CAGR of 6.7% from 2025 to 2030. This growth is primarily fueled by technological advancements in devices such as ventricular assist devices (VADs) and artificial heart pumps, which significantly improve patient survival rates,...